ERM, the world’s largest pureplay sustainability consultancy, and its majority shareholders, OMERS Private Equity and AIMCo on the sale of ERM to KKR.

Exponent Private Equity on the sale of the BBI Group to Novo Holdings, a world-leading life science investor; and on the sale of BBI Healthcare to Venture Life Group, a leader in developing, manufacturing and commercialising products for the international self-care market.

PAI Partners on the simultaneous acquisitions of Addo Food Group (Addo) and Winterbotham Darby from LDC and Equistone (respectively) and existing management.

Charterhouse, through its wholly owned subsidiary Tiger Acquisitions UK, on its cash bid for Tarsus Group.

Exponent Private Equity and its portfolio company, Moonpig, on the demerger of Moonpig from another Exponent portfolio company, Photobox Group, the refinancing of each of Moonpig and Photobox and the subsequent IPO of Moonpig.

Bridgepoint on its acquisition of Fishawack, an independent global healthcare communication group from Lloyds Development Capital.

Exponent on the merger of Photobox and Albelli.

The Consortium on the sale of New Scientist Group Limited, the renowned weekly science and technology magazine, to the Daily Mail and General Trust.

Charterhouse Capital Partners on its public to private acquisition of Tarsus Group plc, an operator of business-to-business exhibitions.

Exponent Private Equity on its acquisition of the TRS Group, a family owned supplier of wholesale ethnic foods from TRS Group (UK) Limited.

Advent International on the sale of allnex Group to Netherlands-based PTTGC International (Netherlands) B.V., a wholly owned subsidiary of Bangkok-based PTT Global Chemical Public Company Limited (“PTTGC”).

Exponent Private Equity on the sale of the Loch Lomond Distillers Group to Hillhouse Capital Management.

Exponent on the sale of Fintrax, one of the world's biggest providers of tax free shopping and dynamic currency conversion, to French private equity firm Eurazeo.